| Donald L Bumgarner, MD | |
|
1 Jack Foster Dr, Shenandoah, IA 51601-4586 | |
| (712) 246-7400 | |
| (712) 246-7334 |
| Full Name | Donald L Bumgarner |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 44 Years |
| Location | 1 Jack Foster Dr, Shenandoah, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518055847 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 25365 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Shenandoah Medical Center | Shenandoah, IA | Hospital |
| Accura Healthcare Of Shenandoah | Shenandoah, IA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shenandoah Medical Center | 9436063237 | 36 |
News Archive
One of the banes of modern cancer therapy is that clinicians and patients must often wait months before they can tell if a given treatment is working.
Intellect Neurosciences, Inc a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has received a Notice of Allowance from the United States Patent and Trademark Office related to RV01 and RV02, the Company's two lead vaccine candidates. The Notice of Allowance is a written communication stating that the patent application has been allowed and will be granted as a new patent. RV01 and RV02, generated using the Company's RECALL-VAX technology, have the potential to delay the onset of or prevent Alzheimer's disease in individuals susceptible by age, genetic or other risk factor.
Researchers studying neurological diseases face several daunting challenges. For one thing, these conditions may take years or even decades to develop.
Aging vessels connecting the brain and the immune system play critical roles in both Alzheimer's disease and the decline in cognitive ability that comes with time, new research reveals.
A coalition of AIDS organizations is asking the Obama administration to investigate whether some insurers are trying to discourage HIV-infected patients from enrolling in their policies by failing to cover some AIDS drugs or through what it called "egregious cost-sharing designs." Other stories explore the law's impact on African-Americans and small businesses.
› Verified 5 days ago
| Entity Name | Shenandoah Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497810972 PECOS PAC ID: 9436063237 Enrollment ID: O20040209000347 |
News Archive
One of the banes of modern cancer therapy is that clinicians and patients must often wait months before they can tell if a given treatment is working.
Intellect Neurosciences, Inc a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has received a Notice of Allowance from the United States Patent and Trademark Office related to RV01 and RV02, the Company's two lead vaccine candidates. The Notice of Allowance is a written communication stating that the patent application has been allowed and will be granted as a new patent. RV01 and RV02, generated using the Company's RECALL-VAX technology, have the potential to delay the onset of or prevent Alzheimer's disease in individuals susceptible by age, genetic or other risk factor.
Researchers studying neurological diseases face several daunting challenges. For one thing, these conditions may take years or even decades to develop.
Aging vessels connecting the brain and the immune system play critical roles in both Alzheimer's disease and the decline in cognitive ability that comes with time, new research reveals.
A coalition of AIDS organizations is asking the Obama administration to investigate whether some insurers are trying to discourage HIV-infected patients from enrolling in their policies by failing to cover some AIDS drugs or through what it called "egregious cost-sharing designs." Other stories explore the law's impact on African-Americans and small businesses.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Donald L Bumgarner, MD 1 Jack Foster Dr, Shenandoah, IA 51601-4586 Ph: (712) 246-7400 | Donald L Bumgarner, MD 1 Jack Foster Dr, Shenandoah, IA 51601-4586 Ph: (712) 246-7400 |
News Archive
One of the banes of modern cancer therapy is that clinicians and patients must often wait months before they can tell if a given treatment is working.
Intellect Neurosciences, Inc a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has received a Notice of Allowance from the United States Patent and Trademark Office related to RV01 and RV02, the Company's two lead vaccine candidates. The Notice of Allowance is a written communication stating that the patent application has been allowed and will be granted as a new patent. RV01 and RV02, generated using the Company's RECALL-VAX technology, have the potential to delay the onset of or prevent Alzheimer's disease in individuals susceptible by age, genetic or other risk factor.
Researchers studying neurological diseases face several daunting challenges. For one thing, these conditions may take years or even decades to develop.
Aging vessels connecting the brain and the immune system play critical roles in both Alzheimer's disease and the decline in cognitive ability that comes with time, new research reveals.
A coalition of AIDS organizations is asking the Obama administration to investigate whether some insurers are trying to discourage HIV-infected patients from enrolling in their policies by failing to cover some AIDS drugs or through what it called "egregious cost-sharing designs." Other stories explore the law's impact on African-Americans and small businesses.
› Verified 5 days ago
Dr. Todd Mikael Isaacson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Jack Foster Dr, Shenandoah, IA 51601 Phone: 712-246-7400 Fax: 712-246-7334 | |
Jacy Bayless, ARNP Family Medicine Medicare: Medicare Enrolled Practice Location: 300 Pershing Ave, Shenandoah, IA 51601 Phone: 712-246-7400 | |
John Bowery, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 300 Pershing Ave, Shenandoah, IA 51601 Phone: 712-374-6005 Fax: 712-374-2301 | |
Dr. Heather Lee Babe, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Jack Foster Dr, Shenandoah, IA 51601 Phone: 712-246-7400 | |
Dr. Michael Theodore Salwitz, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Jack Foster Dr, Shenandoah, IA 51601 Phone: 712-246-7400 Fax: 712-246-7334 |